(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6diazabicyclo[3.2.0]heptane benzenesulfonate

Details for Australian Patent Application No. 2009202832 (hide)

Owner Abbott Laboratories

Inventors Willcox, David R.; Mellican, Sean M.; Zhang, Geoff G.; Breting, Jeffrey M.; Wayne, Greg S.

Agent Spruson & Ferguson

Pub. Number AU-B-2009202832

Parent 2005275299

Filing date 13 July 2009

Wipo publication date 6 August 2009

Acceptance publication date 10 November 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

30 July 2009 Complete Application Filed

6 August 2009 Application Open to Public Inspection

  Published as AU-B-2009202832

10 November 2011 Application Accepted

  Published as AU-B-2009202832

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202833-Differentiation of surgical filaments

2009202831-System and method for toy adoption and marketing